Navigation Links
First Public Showing of Innovative Waste-to-Energy Process
Date:12/1/2009

California waste-to-energy firm claims first place in speed, environmental purity, carbon sequesteration, smallest footprint, salable pure gas, byproducts, and return on invested dollar.

(PRWEB) December 15, 2009 -- The first public showing of VRAD©, a new innovative organic waste-to-energy process will take place at the Pacific West Biomass Conference in January.

This biowaste process known as VRAD© accepts all urban farm, factory, commercial, garbage and trash waste streams to produce abundant amounts of clean CBM (compressed biomethane) a gas with a slightly higher Btu value than natural gas.

VRAD© now the first and only completely enclosed, smallest footprint and Environmentally Pure Waste-to-Energy Process. “We could build one next to City Hall”, Miller said with a grin”.
“We have gone the extra mile” said Herman P. Miller II, PE and president of Environmental Developers Inc. (EDI) a Vacaville California Company developer of the patented process. “It took 30 years but we did it”, he continued.

Not only does the Company claim to have the most efficient high temperature biomass digestion system in the world today but the VRAD© Process will produce clean gas, separates out and sequesters the Carbon Dioxide gas, and recycles pure water.

VRAD© a high tech approach to a typically low tech technology, is applicable to cities and urban areas with excesses of 500-1000 tons a day of biomass refuge. The sale of CBM, water, and other available byproducts, such as Epson Salts and Bicarbonate of Soda, dependent upon the type of feedstock available and market forces will return capital costs in 5-7 years and produce a tidy return to its investors” Miller claims.

The Sacramento, California biomass conference sponsored in part by Biomass Magazine will parade the biomass industries newest offerings at the Hyatt Regency January 11-13, 2010.

###

Read the full story at http://www.prweb.com/releases/2009/12/prweb3262934.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM)
2. deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court
3. YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA
4. Knome Launches First Platform-Agnostic Human Genome Sequencing and Analysis Service for Researchers
5. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2010 Results; Teleconference and Webcast to be held on November 16, 2009
6. NOVAVAX Completes First Stage of Enrollment in Pivotal H1N1 Influenza Vaccine Study in the Country of Mexico
7. YM BIOSCIENCES REPORTS FISCAL FIRST QUARTER 2010 OPERATIONAL AND FINANCIAL RESULTS
8. Cellerix Raises EUR27 Million in a First Closing
9. intendiX - Communication by Thoughts: First Patient-Ready System on the Market
10. ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line
11. Monsanto Opens First Biotechnology Research Center in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... -- Global demand for enzymes is forecast to grow ... billion.  This market includes enzymes used in industrial ... animal feed, and other markets) and specialty applications ... beverages will remain the largest market for enzymes, ... containing enzymes in developing regions.  These and other ...
(Date:6/27/2016)... NC (PRWEB) , ... June 27, 2016 , ... ... mission to bring innovative medical technologies, services and solutions to the healthcare market. ... and implementation of various distribution, manufacturing, sales and marketing strategies that are necessary ...
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
Breaking Biology Technology:
(Date:4/13/2016)... 2016  IMPOWER physicians supporting Medicaid patients in ... clinical standard in telehealth thanks to a new partnership ... platform, IMPOWER patients can routinely track key health measurements, ... index, and, when they opt in, share them with ... a local retail location at no cost. By leveraging ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
Breaking Biology News(10 mins):